Search results
Your search for ���������������������������������:kn39��������� ������ ������ ������ returned no results
Showing 106 to 120 of 815 results for ���������������������������������:know��������� ������ ������ ������
Showing 106 to 120 of 815 results for ���������������������������������:know��������� ������ ������ ������
Evidence-based recommendations on voretigene neparvovec (Luxturna) for RPE65-mediated inherited retinal dystrophies in people with vision loss caused by inherited retinal dystrophy from confirmed biallelic RPE65 mutations and who have sufficient viable retinal cells.
from mesh surgery on page 12 of this decision aid. It is not possible to know for sure what will happen to any individual woman 4 More...
Evidence-based recommendations on givosiran (Givlaari) for treating acute hepatic porphyria in adults and young people aged 12 and over.
Evidence-based recommendations on velmanase alfa (Lamzede) for treating alpha-mannosidosis in people under 18 years and in people who turn 18 while on treatment.
Inotersen for treating hereditary transthyretin amyloidosis (HST9)
Evidence-based recommendations on inotersen (Tegsedi) for stage 1 and stage 2 polyneuropathy in adults with hereditary transthyretin amyloidosis.
your GP for a review within 12 months, or an earlier agreed time. If you know that something triggers a UTI you could take an antibiotic...
involved in making choices about your care. To make a decision, you need to know what your options are and what might happen if you...
A quick guide to enabling positive lives for autistic adults for social workers.
with and what are you willing for them to share? Information . Do you know who to contact for more advice if your needs change? Future...
Improving young people's experiences in transition to and from inpatient mental health settings
A quick guide for mental health practitioners supporting young people transitioning to and from inpatient mental health settings
The process by which organisations can register as stakeholders with NICE.
This quality standard covers care for adults (aged 18 and over) who are approaching the end of their life. This includes people who are likely to die within 12 months, people with advanced, progressive, incurable conditions and people with life-threatening acute conditions. It also covers support for their families and carers. It includes care provided by health and social care staff in all settings. It describes high-quality care in priority areas for improvement.
A quick guide for care home managers and home care managers providing medicines support
This quality standard covers assessing, diagnosing and managing bronchiolitis in children. It describes high-quality care in priority areas for improvement.
Commentary by Professor Russell Viner from the Royal College of Paediatrics and Child Health